Pulmonary hypertension in adults with and without congenital heart disease: Different strokes for different folks

Abstract

Get full access to this article

View all access options for this article.

References

Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. Epub ahead of print 10 August 2018. DOI: 10.1016/j.jacc.2018.08.1028.

Khan A and Gurvitz M. Epidemiology of ACHD: what has changed and what is changing? Prog Cardiovasc Dis. Epub ahead of print 17 August 2018. DOI: 10.1016/j.pcad.2018.08.004.

Fathallah M and Krasuski RA. A multifaceted approach to pulmonary hypertension in adults with congenital heart disease. Prog Cardiovasc Dis. Epub ahead of print 18 July 2018. DOI: 10.1016/j.pcad.2018.07.017.

Guazzi

Adams

Conraads

et al.

European Association for Cardiovascular Prevention and Rehabilitation; American Heart Association. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J 2012; 33: 2917–2927.

Lavie CJ, Shah SB and Mehra MR. The dilemma of exertional dyspnea and diagnosis of heart failure: convergent and discriminant validity. JACC Cardiovasc Imaging 2018; pii: S1936–878X(17)30978-6. DOI: 10.1016/j.jcmg.2017.09.014.

Milani

Lavie

Mehra

et al.

Understanding the basics of cardiopulmonary exercise testing. Mayo Clin Proc 2006; 81: 1603–1611.

Milani

Lavie

Mehra

. Cardiopulmonary exercise testing: how do we differentiate the cause of dyspnea? Circulation 2004; 110: e27–e31.

Balady

Arena

Sietsema

et al.

Clinician’s guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation 2010; 122: 191–225.

Guazzi

Arena

Halle

et al.

2016 Focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J 2018; 39: 1144–1161.

10.

Huang

Resch

Oliveira

et al.

Invasive cardiopulmonary exercise testing in the evaluation of unexplained dyspnea: Insights from a multidisciplinary dyspnea center. Eur J Prev Cardiol 2017; 24: 1190–1199.

11.

Arena

Lavie

Milani

et al.

Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review. J Heart Lung Transplant 2010; 29: 159–173.

12.

Arena

Guazzi

Myers

et al.

Cardiopulmonary exercise testing in the assessment of pulmonary hypertension. Expert Rev Resp Med 2011; 5: 281–293.

13.

Righini FM, Apostolo A, Heck PB, et al. Exercise physiology in pulmonary hypertension patients with and without congenital heart disease. Eur J Prev Cardiol 2019; 26: 86–93.

14.

Cahalin

Chase

Arena

et al.

A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure. Heart Fail Rev 2013; 18: 79–94.

15.

Kempny

Dimopoulos

Uebing

et al.

Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life – single centre experience and review of published data. Eur Heart J 2012; 33: 1386–1396.

16.

Mantegazza

Apostolo

Hager

. Cardiopulmonary exercise testing in adult congenital heart disease. Ann Am Thorac Soc 2017; 14(Suppl. 1): S93–S101.

17.

Dimopoulous

Okonko

Diller

et al.

Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival. Circulation 2006; 113: 2796–2802.

18.

Valli

Vizza

Onorati

et al.

Pathophysiological adaptations to walking and cycling in primary pulmonary hypertension. Eur J Appl Physiol 2008; 102: 417–424.

19.

Häcker

Reiner

Oberhoffer

et al.

Increased arterial stiffness in children with congenital heart disease. Eur J Prev Cardiol 2018; 25: 103–109.